Literature DB >> 10820439

Phospholipid incorporation and metabolic conversion of n-3 polyunsaturated fatty acids in the Y79 retinoblastoma cell line.

B Goustard-Langelier1, J M Alessandri, G Raguenez, G Durand, Y Courtois.   

Abstract

The metabolic conversion of n-3 fatty acids was studied in the human Y79 retinoblastoma cell line. Cultured cells were exposed to increasing concentrations of either 18:3n-3, 22:5n-3, or 22:6n-3, and their phospholipid fatty acid composition was analyzed after 72 hr. Cells internalized the supplemental fatty acids and proceeded to their metabolic conversion. Supplemental 22:6n-3 was directly esterified into cell phospholipids, at levels typical for normal neural retinas (41% by weight of phosphatidylethanolamine fatty acids, and 24% of phosphatidylcholine fatty acids). In contrast, 18:3n-3 was mainly converted to 20:5n-3 and 22:5n-3, both of which appeared in cell phospholipids after exposure to low external concentrations of 18:3n-3 (10 microg/ml). Y79 cells can proceed to the metabolic conversion of 18:3n-3 through elongation and Delta6- and Delta5-desaturation. When cells were exposed to high external concentrations of 18:3n-3 (30 microg/ml), the supplemental fatty acid was directly incorporated, and its relative content increased in both phospholipid classes to the detriment of all other n-3 fatty acids. Cells cultured in the presence of 22:5n-3 did not incorporate 22:6n-3 into their phospholipids but did incorporate 20:5n-3 and 22:5n-3. The data suggest that Y79 cells can proceed to the microsomal steps of n-3 metabolism, involving elongation, desaturation, and chain shortening of 22C fatty acids. Although Y79 cells avidly used supplemental 22:6n-3 for phospholipid incorporation at levels typical for normal photoreceptor cells, they failed to match such levels through metabolic conversion of n-3 parent fatty acids. The terminal step of the very long-chain polyunsaturated fatty acid synthesis, consisting in Delta6-desaturation followed by peroxisomal chain shortening of 24C-fatty acids, could be rate-limiting in Y79 cells. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820439     DOI: 10.1002/(SICI)1097-4547(20000601)60:5<678::AID-JNR13>3.0.CO;2-T

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Incorporation of alpha-linolenic acid and linoleic acid into human respiratory epithelial cell lines.

Authors:  D L Bryan; P Hart; K Forsyth; R Gibson
Journal:  Lipids       Date:  2001-07       Impact factor: 1.880

2.  Changes of the transcriptional and fatty acid profiles in response to n-3 fatty acids in SH-SY5Y neuroblastoma cells.

Authors:  Bénédicte Langelier; Jean-Marc Alessandri; Marie-Hélène Perruchot; Philippe Guesnet; Monique Lavialle
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

3.  Polyunsaturated fatty acids induce modification in the lipid composition and the prostaglandin production of the conjunctival epithelium cells.

Authors:  Sabrina Viau; Laurent Leclère; Bénédicte Buteau; Stéphane Grégoire; Niyazi Acar; Alain Bron; Catherine P Creuzot-Garcher; Lionel Bretillon; Corinne Joffre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-06       Impact factor: 3.117

4.  Estradiol favors the formation of eicosapentaenoic acid (20:5n-3) and n-3 docosapentaenoic acid (22:5n-3) from alpha-linolenic acid (18:3n-3) in SH-SY5Y neuroblastoma cells.

Authors:  Jean-Marc Alessandri; Audrey Extier; Bénédicte Langelier; Marie-Hélène Perruchot; Christine Heberden; Philippe Guesnet; Monique Lavialle
Journal:  Lipids       Date:  2007-10-03       Impact factor: 1.880

5.  Relative quantification of deuterated omega-3 and -6 fatty acids and their lipid turnover in PC12 cell membranes using TOF-SIMS.

Authors:  Mai H Philipsen; Sanna Sämfors; Per Malmberg; Andrew G Ewing
Journal:  J Lipid Res       Date:  2018-09-11       Impact factor: 5.922

6.  Colorimetric and longitudinal analysis of leukocoria in recreational photographs of children with retinoblastoma.

Authors:  Alireza Abdolvahabi; Brandon W Taylor; Rebecca L Holden; Elizabeth V Shaw; Alex Kentsis; Carlos Rodriguez-Galindo; Shizuo Mukai; Bryan F Shaw
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.